I became part of Genentech's Clinical Pharmacology Modeling & Simulation group in 2016, following my Ph.D. in Pharmaceutical Sciences from the University of Tokyo and a postdoctoral fellowship at the FDA. Throughout my time at Genentech, I've had the chance to refine my expertise in various modeling and simulation approaches, applying them to make a meaningful impact on a wide array of clinical development projects.
Clin Transl Sci. 2023 Apr;16(4):694-703. doi: 10.1111/cts.13483. Epub 2023 Feb 8.